pharmaphorum

DECEMBER 16, 2020

Soon the ABPI and the entire industry were facing the ripple effects of COVID-19, including a significant slowdown in non-COVID clinical research, which Torbett says was challenging for the industry to deal with. “We’ve We had companies collaborating to develop laboratories. Strength in the second wave.

Vaccination 122

Vaccination Vaccine Life Science In-Vitro 122

pharmaphorum

OCTOBER 18, 2021

There was a genuine sense of alliance; regulatory bodies and pharma companies coming together to accelerate processes and find the most optimal model for collaboration. Also worth exploring is the regulatory oversight and approval process for medical devices and in-vitro diagnostics (IVDs). And there are many.

Vaccination 143

Vaccination Vaccine Regulation Medicine 143

XTalks

OCTOBER 1, 2020

To gain insight into the motivations, steps and experiences involved in an academia to industry — or vice versa — transition, Xtalks spoke to several leading scientists and entrepreneurs in pharma and biotech who successfully transitioned from academic positions to leadership roles in industry settings. Key Moments.

Scientist 52

Scientist In-Vitro Research Life Science 52